Literature DB >> 26043250

[Analysis of patient flows: basis for regional control of antibiotic resistance].

Tjibbe Donker1, Mariano Ciccolini, Jacco Wallinga, Jan A J W Kluytmans, Hajo Grundmann, Alexander W Friedrich.   

Abstract

Antibiotic resistance is a worldwide threat to health care as it impairs the effective treatment of bacterial infections. Measures against the spread of resistance are mainly focused on individual health care institutions as these are viewed as the main source of resistance. However, health care institutions are not completely independent in their control of the prevalence of resistance, as movement of patients between hospitals and care institutions can induce movement of resistant micro-organisms. In other words, antibiotic resistance follows the flow of patients. Mapping this flow of patients results in a network that includes all health care institutions, and has a distinctive modular structure. Patients are moved primarily within regions, much less so between regions. We argue that the structure of this health care network should be used to design efficient and effective control strategies. To this end, we advocate (a) regional coordination of control measures, (b) differentiation of investment in infection prevention according to the network position of the institution, and (c) setting up sentinel surveillance based on the health care network.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26043250

Source DB:  PubMed          Journal:  Ned Tijdschr Geneeskd        ISSN: 0028-2162


  2 in total

1.  The Role of Nursing Homes in the Spread of Antimicrobial Resistance Over the Healthcare Network.

Authors:  Carline van den Dool; Anja Haenen; Tjalling Leenstra; Jacco Wallinga
Journal:  Infect Control Hosp Epidemiol       Date:  2016-04-07       Impact factor: 3.254

2.  Association between rectal colonization with Highly Resistant Gram-negative Rods (HR-GNRs) and subsequent infection with HR-GNRs in clinical patients: A one year historical cohort study.

Authors:  Dennis Souverein; Sjoerd M Euser; Bjorn L Herpers; Jan Kluytmans; John W A Rossen; Jeroen W Den Boer
Journal:  PLoS One       Date:  2019-01-25       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.